Section Arrow
Quote
VIR.NASDAQ
- Vir Biotechnology
Quotes are at least 15-min delayed:2024/12/24 12:56 EST
Last
 7.375
+0.035 (+0.48%)
Day High 
7.45 
Prev. Close
7.34 
1-M High
10 
Volume 
312.99K 
Bid
7.37
Ask
7.38
Day Low
7.145 
Open
7.35 
1-M Low
7.025 
Market Cap 
1.01B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 7.49 
20-SMA 7.83 
50-SMA 8.01 
52-W High 13.09 
52-W Low 6.56 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.93/-3.20
Enterprise Value
1.12B
Balance Sheet
Book Value Per Share
9.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
39.49M
Operating Revenue Per Share
0.38
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.384-0.0191-4.74%-- 
CMNDClearmind Medicine1.7+0.48+39.34%0.16PE
CEROCERo Therapeutics Holdings0.0603+0.0098+19.41%-- 
RXRXRecursion Pharmaceuticals7.275+0.285+4.08%-- 
CDTConduit Pharmaceuticals0.0576+0.0031+5.69%-- 
Quotes are at least 15-min delayed：2024/12/24 12:56 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development,collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.